Methods for increasing adiponectin in a patient in need thereof
    81.
    发明授权
    Methods for increasing adiponectin in a patient in need thereof 有权
    在有需要的患者中增加脂连蛋白的方法

    公开(公告)号:US08138142B2

    公开(公告)日:2012-03-20

    申请号:US12657146

    申请日:2010-01-13

    Abstract: In certain aspects, the present invention provides compositions and methods for increasing adiponectin in a patient in need thereof by administering an antagonist of an ActRIIB signaling pathway. Examples of such antagonists include ActRIIB polypeptides, anti-ActRIIB antibodies, anti-activin A and/or B antibodies, anti-myostatin antibodies, anti-GDF3 antibodies, and anti-BMP7 antibodies. Also provided are methods for ameliorating one or more undesired effects of anti-androgen therapy, including muscle loss, bone loss, increased adiposity, and/or increased insulin resistance. A variety of disorders may be treated by causing an increase in circulating adiponectin concentrations.

    Abstract translation: 在某些方面,本发明提供了通过施用ActRIIB信号通路的拮抗剂来增加有需要的患者中的脂连蛋白的组合物和方法。 此类拮抗剂的实例包括ActRIIB多肽,抗ActRIIB抗体,抗激活素A和/或B抗体,抗肌生成抑制素抗体,抗GDF3抗体和抗BMP7抗体。 还提供了用于改善一种或多种不期望的抗雄激素治疗效果的方法,包括肌肉损失,骨丢失,增加的肥胖和/或增加的胰岛素抵抗。 可以通过引起循环中脂联素浓度的增加来治疗多种疾病。

Patent Agency Ranking